Showing results (1221-1230 of 1,385) with videos related to

Sort By:
Pageof 139
JAMA Network Open|August 5, 2025
Incidence, Prevalence, and Stability of Remission in Individuals With Clinical High Risk for PsychosisJohanna Seitz-Holland, Grace R Jacobs, Jenna Reinen, et al.
Schizophrenia Research|March 3, 2024
A naturalistic cohort study of first-episode schizophrenia spectrum disorder: A description of the early phase of illness in the PSYSCAN cohortMargot I E Slot, Hendrika H van Hell, Inge Winter-van Rossum, et al.
Nature Human Behaviour|August 7, 2019
Shared vulnerability for connectome alterations across psychiatric and neurological brain disordersSiemon C de Lange, Lianne H Scholtens, , et al.
Schizophrenia Research|May 4, 2019
Longitudinal evidence for a relation between depressive symptoms and quality of life in schizophrenia using structural equation modelingGeeske van Rooijen, Maaike van Rooijen, Arija Maat, et al.
Psychological Medicine|October 11, 2018
The characteristics of psychotic features in bipolar disorderAnnet H van Bergen, Sanne Verkooijen, Annabel Vreeker, et al.
The Lancet. Psychiatry|December 3, 2023
Relapse in clinically stable adult patients with schizophrenia or schizoaffective disorder: evidence-based criteria derived by equipercentile linking and diagnostic test accuracy meta-analysisSpyridon Siafis, Lasse Brandt, Robert A McCutcheon, et al.
Psychiatry Research|August 31, 2017
An experience sampling study on the ecological validity of the SWN-20: Indication that subjective well-being is associated with momentary affective states above and beyond psychosis susceptibilityKarin Pos, Iris E de Wit, Floor A van Dijk, et al.
Molecular Psychiatry|January 16, 2013
Genome-wide association study of monoamine metabolite levels in human cerebrospinal fluidJ J Luykx, S C Bakker, E Lentjes, et al.
Molecular Psychiatry|February 11, 2015
Genome-wide association study of NMDA receptor coagonists in human cerebrospinal fluid and plasmaJ J Luykx, S C Bakker, W F Visser, et al.
Schizophrenia (Heidelberg, Germany)|October 7, 2024
Multivariable prediction of functional outcome after first-episode psychosis: a crossover validation approach in EUFEST and PSYSCANMargot I E Slot, Maria F Urquijo Castro, Inge Winter-van Rossum, et al.
Pageof 139